40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.51%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
15.86%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
3.37%
Gross profit growth below 50% of CRK's 10.18%. Michael Burry would check for structural issues.
-4.74%
Margin decline while CRK shows 11.17% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-10.83%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
175.00%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
-11.33%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
2.95%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
-3.16%
Both companies reducing interest expense. Martin Whitman would check industry trends.
13.17%
D&A growth while CRK reduces D&A. John Neff would investigate differences.
21.09%
EBITDA growth below 50% of CRK's 186.39%. Michael Burry would check for structural issues.
23.82%
EBITDA margin growth exceeding 1.5x CRK's 1.40%. David Dodd would verify competitive advantages.
28.63%
Operating income growth below 50% of CRK's 78.86%. Michael Burry would check for structural issues.
18.54%
Operating margin growth below 50% of CRK's 78.66%. Michael Burry would check for structural issues.
-53.91%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
8.84%
Pre-tax income growth below 50% of CRK's 32.42%. Michael Burry would check for structural issues.
0.31%
Pre-tax margin growth below 50% of CRK's 31.82%. Michael Burry would check for structural issues.
-97.61%
Tax expense reduction while CRK shows 103.09% growth. Joel Greenblatt would examine advantage.
165.94%
Net income growth exceeding 1.5x CRK's 0.97%. David Dodd would verify competitive advantages.
160.77%
Net margin growth exceeding 1.5x CRK's 0.08%. David Dodd would verify competitive advantages.
167.80%
EPS growth exceeding 1.5x CRK's 2.80%. David Dodd would verify competitive advantages.
167.80%
Diluted EPS growth exceeding 1.5x CRK's 2.80%. David Dodd would verify competitive advantages.
-0.12%
Share count reduction while CRK shows 1.86% change. Joel Greenblatt would examine strategy.
-0.16%
Diluted share reduction while CRK shows 1.86% change. Joel Greenblatt would examine strategy.